Kailera Therapeutics, Inc. (KLRA)

CIK 2096997 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kailera Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 202630001193125-26-386778
Sep 9, 202640001193125-26-386782
Aug 14, 2026SCHEDULE 13G0001493215-26-000151
Aug 14, 2026SCHEDULE 13G0001193125-26-352133
Aug 12, 20268-K0001193125-26-346919
Aug 12, 202610-Q0001193125-26-346958
Aug 5, 2026SCHEDULE 13G0001104659-26-090642
Jul 8, 202630001193125-26-298547
Jul 8, 202640001193125-26-298558
Jun 11, 202640001193125-26-267493
May 26, 20268-K0001193125-26-239362
May 26, 202610-Q0001193125-26-239417
Apr 23, 2026SCHEDULE 13D0001193125-26-174293
Apr 23, 2026SCHEDULE 13D0001193125-26-174330
Apr 22, 202640001231919-26-000390
Apr 22, 202640001104659-26-046276
Apr 20, 202640001193125-26-164275
Apr 20, 202640001193125-26-164243
Apr 20, 202640001193125-26-164226
Apr 20, 202640001193125-26-164253
Apr 20, 202640001193125-26-164389
Apr 20, 202640001193125-26-164264
Apr 20, 202640001193125-26-164307
Apr 20, 20268-K0001193125-26-164040
Apr 20, 202640001193125-26-164407